Literature DB >> 26661224

Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer's disease.

Pamela V Martino Adami1, Celia Quijano2, Natalia Magnani3, Pablo Galeano1,4, Pablo Evelson3, Adriana Cassina2, Sonia Do Carmo5, María C Leal6, Eduardo M Castaño1, A Claudio Cuello5, Laura Morelli7.   

Abstract

Synaptic bioenergetic deficiencies may be associated with early Alzheimer's disease (AD). To explore this concept, we assessed pre-synaptic mitochondrial function in hemizygous (+/-)TgMcGill-R-Thy1-APP rats. The low burden of Aβ and the wide array of behavioral and cognitive impairments described in 6-month-old hemizygous TgMcGill-R-Thy1-APP rats (Tg(+/-)) support their use to investigate synaptic bioenergetics deficiencies described in subjects with early Alzheimer's disease (AD). In this report, we show that pre-synaptic mitochondria from Tg(+/-) rats evidence a decreased respiratory control ratio and spare respiratory capacity associated with deficits in complex I enzymatic activity. Cognitive impairments were prevented and bioenergetic deficits partially reversed when Tg(+/-) rats were fed a nutritionally complete diet from weaning to 6-month-old supplemented with pyrroloquinoline quinone, a mitochondrial biogenesis stimulator with antioxidant and neuroprotective effects. These results provide evidence that, as described in AD brain and not proven in Tg mice models with AD-like phenotype, the mitochondrial bioenergetic capacity of synaptosomes is not conserved in the Tg(+/-) rats. This animal model may be suitable for understanding the basic biochemical mechanisms involved in early AD.
© The Author(s) 2015.

Entities:  

Keywords:  Amyloid β; early-Alzheimer; hippocampal bioenergetics status; neurodegeneration; synaptosomes

Mesh:

Substances:

Year:  2015        PMID: 26661224      PMCID: PMC5363729          DOI: 10.1177/0271678X15615132

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  53 in total

Review 1.  Cell biology of the presynaptic terminal.

Authors:  Venkatesh N Murthy; Pietro De Camilli
Journal:  Annu Rev Neurosci       Date:  2003       Impact factor: 12.449

Review 2.  The measurement of oxidative damage to DNA by HPLC and GC/MS techniques.

Authors:  B Halliwell; M Dizdaroglu
Journal:  Free Radic Res Commun       Date:  1992

3.  Mitochondrial complex I plays an essential role in human respirasome assembly.

Authors:  David Moreno-Lastres; Flavia Fontanesi; Inés García-Consuegra; Miguel A Martín; Joaquín Arenas; Antoni Barrientos; Cristina Ugalde
Journal:  Cell Metab       Date:  2012-02-16       Impact factor: 27.287

Review 4.  Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease.

Authors:  K Chandrasekaran; K Hatanpää; D R Brady; S I Rapoport
Journal:  Exp Neurol       Date:  1996-11       Impact factor: 5.330

Review 5.  Oxidative stress and energy crises in neuronal dysfunction.

Authors:  David G Nicholls
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

6.  Transcriptional regulation of insulin-degrading enzyme modulates mitochondrial amyloid β (Aβ) peptide catabolism and functionality.

Authors:  María C Leal; Natalia Magnani; Sergio Villordo; Cristina Marino Buslje; Pablo Evelson; Eduardo M Castaño; Laura Morelli
Journal:  J Biol Chem       Date:  2013-03-22       Impact factor: 5.157

7.  Beneficial synergistic effects of microdose lithium with pyrroloquinoline quinone in an Alzheimer's disease mouse model.

Authors:  Lei Zhao; Neng Gong; Meng Liu; Xiaoli Pan; Shaoming Sang; Xiaojing Sun; Zhe Yu; Qi Fang; Na Zhao; Guoqiang Fei; Lirong Jin; Chunjiu Zhong; Tianle Xu
Journal:  Neurobiol Aging       Date:  2014-06-14       Impact factor: 4.673

8.  The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury.

Authors:  F E Jensen; G J Gardner; A P Williams; P M Gallop; E Aizenman; P A Rosenberg
Journal:  Neuroscience       Date:  1994-09       Impact factor: 3.590

9.  Longitudinal testing of hippocampal plasticity reveals the onset and maintenance of endogenous human Aß-induced synaptic dysfunction in individual freely behaving pre-plaque transgenic rats: rapid reversal by anti-Aß agents.

Authors:  Yingjie Qi; Igor Klyubin; Sarah C Harney; NengWei Hu; William K Cullen; Marianne K Grant; Julia Steffen; Edward N Wilson; Sonia Do Carmo; Stefan Remy; Martin Fuhrmann; Karen H Ashe; A Claudio Cuello; Michael J Rowan
Journal:  Acta Neuropathol Commun       Date:  2014-12-24       Impact factor: 7.801

Review 10.  Modeling Alzheimer's disease in transgenic rats.

Authors:  Sonia Do Carmo; A Claudio Cuello
Journal:  Mol Neurodegener       Date:  2013-10-25       Impact factor: 14.195

View more
  16 in total

Review 1.  Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.

Authors:  Robert B Cameron; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2016-09-27       Impact factor: 7.446

2.  Perturbed mitochondria-ER contacts in live neurons that model the amyloid pathology of Alzheimer's disease.

Authors:  Pamela V Martino Adami; Zuzana Nichtová; David B Weaver; Adam Bartok; Thomas Wisniewski; Drew R Jones; Sonia Do Carmo; Eduardo M Castaño; A Claudio Cuello; György Hajnóczky; Laura Morelli
Journal:  J Cell Sci       Date:  2019-10-22       Impact factor: 5.285

Review 3.  Energy matters: presynaptic metabolism and the maintenance of synaptic transmission.

Authors:  Sunan Li; Zu-Hang Sheng
Journal:  Nat Rev Neurosci       Date:  2021-11-15       Impact factor: 34.870

4.  Platelets Bioenergetics Screening Reflects the Impact of Brain Aβ Plaque Accumulation in a Rat Model of Alzheimer.

Authors:  Federico A Prestia; Pablo Galeano; Pamela V Martino Adami; Sonia Do Carmo; Eduardo M Castaño; A Claudio Cuello; Laura Morelli
Journal:  Neurochem Res       Date:  2018-10-24       Impact factor: 3.996

5.  Chronic Hippocampal Expression of Notch Intracellular Domain Induces Vascular Thickening, Reduces Glucose Availability, and Exacerbates Spatial Memory Deficits in a Rat Model of Early Alzheimer.

Authors:  Pablo Galeano; María C Leal; Carina C Ferrari; María C Dalmasso; Pamela V Martino Adami; María I Farías; Juan C Casabona; Mariana Puntel; Sonia Do Carmo; Clara Smal; Martín Arán; Eduardo M Castaño; Fernando J Pitossi; A Claudio Cuello; Laura Morelli
Journal:  Mol Neurobiol       Date:  2018-03-26       Impact factor: 5.590

6.  Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction.

Authors:  Tyler G Demarest; Vijay R Varma; Darlene Estrada; Mansi Babbar; Sambuddha Basu; Uma V Mahajan; Ruin Moaddel; Deborah L Croteau; Madhav Thambisetty; Mark P Mattson; Vilhelm A Bohr
Journal:  Acta Neuropathol       Date:  2020-04-24       Impact factor: 17.088

Review 7.  Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America.

Authors:  Gloria Patricia Cardona-Gómez; Francisco Lopera
Journal:  Front Aging Neurosci       Date:  2016-12-20       Impact factor: 5.750

8.  Deficits in Mitochondrial Spare Respiratory Capacity Contribute to the Neuropsychological Changes of Alzheimer's Disease.

Authors:  Simon M Bell; Matteo De Marco; Katy Barnes; Pamela J Shaw; Laura Ferraiuolo; Daniel J Blackburn; Heather Mortiboys; Annalena Venneri
Journal:  J Pers Med       Date:  2020-04-29

Review 9.  Mitochondrial Bioenergetics and Dynamics in Secretion Processes.

Authors:  Jennyfer Martínez; Inés Marmisolle; Doménica Tarallo; Celia Quijano
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-22       Impact factor: 5.555

10.  BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology.

Authors:  E N Wilson; S Do Carmo; M F Iulita; H Hall; A Ducatenzeiler; A R Marks; S Allard; D T Jia; J Windheim; A C Cuello
Journal:  Transl Psychiatry       Date:  2017-08-01       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.